#VisualAbstract: Immunotherapy plus stereotactic radiotherapy improves outcomes in early-stage lung cancer
1. 4-year event-free survival was significantly greater in I-SABR (77%) versus SABR alone (53%). 2. More patients in the I-SABR ...
Tag: pulmonology
Immunotherapy plus stereotactic radiotherapy improves outcomes in early-stage lung cancer
1. 4-year event-free survival was significantly greater in I-SABR (77%) versus SABR alone (53%). 2. More patients in the I-SABR ...
Generic and brand-name fluticasone-salmeterol are equally effective in COPD management
1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was associated with similar outcomes in chronic obstructive pulmonary disease ...
#VisualAbstract: Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer
1. Median overall survival in the atezolizumab group was 10.3 months versus 9.2 months in the chemotherapy group. 2. Patients ...
Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer
1. Median overall survival in the atezolizumab group was 10.3 months versus 9.2 months in the chemotherapy group. 2. Patients ...
Dupilumab reduces the number exacerbations in patients with COPD and type two inflammation
1. In this randomized controlled trial, dupilumab use was associated with significantly fewer chronic obstructive pulmonary disease (COPD) exacerbations among ...
Changing oxygenation strategies not associated with differences in feeding intolerance in preterm infants
1. In preterm infants with respiratory distress, there was no difference in time to full enteral feeding (FEF), between the ...
Hydrocortisone reduces mortality in severe community-acquired pneumonia
1. Among patients with severe community-acquired pneumonia (CAP) admitted to the intensive care unit (ICU), hydrocortisone reduced the risk of ...
RSV infection in infancy may increase the risk of developing early-onset childhood asthma
1. More patients in the RSV group reported asthma within 5 years compared to those in the non-RSV group. 2. ...
BCG vaccine does not lower risk of COVID-19 infection among healthcare workers
1. In this randomized controlled trial, bacille Calmette-Guerin (BCG) vaccination did not result in a lower risk of contracting coronavirus ...
